Prognostic Stage III Breast Cancer AJCC v8 Withdrawn Phase 2 Trials for Paclitaxel (DB01229)

Also known as: Prognostic Stage 3 Breast Cancer AJCC v8

IndicationStatusPhase
DBCOND0109635 (Prognostic Stage III Breast Cancer AJCC v8)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05177796Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast CancerTreatment